Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (51-60 of 339) with videos related to

Pageof 34
Sort By:
European Journal of Haematology|October 10, 2013
The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in GermanyNorbert Gattermann, Andrea Kündgen, Lenka Kellermann, et al.
Annals of Hematology|June 26, 2008
Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromesUlrich Germing, Carlo Aul, Charlotte M Niemeyer, et al.
Frontiers in Oncology|January 1, 2024
Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potentialAnna Maria Cacic, Felicitas Isabel Schulz, Ulrich Germing, et al.
Chemotherapy|September 6, 2007
Complete remission of a metastatic pancreatic carcinoma after modified G-FLIP therapyIngo Alldinger, Antonis G Tsamaloukas, Ulrich Germing, et al.
Haematologica|June 15, 2004
Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximabHolger Schulz, Hendrik Pels, Ingo Schmidt-Wolf, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemiaBrigitte Royer-Pokora, Detlef Trost, Nicola Müller, et al.
Cancer Genetics and Cytogenetics|February 24, 2006
Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemiaDetlef Trost, Barbara Hildebrandt, Manfred Beier, et al.
British Journal of Haematology|May 12, 2015
In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over timeMichael Lauseker, Jennifer Schemenau, Corinna Strupp, et al.
Leukemia Research|March 17, 2012
Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromesUlrich Germing, Corinna Strupp, Aristoteles Giagounidis, et al.
Frontiers in Oncology|April 26, 2024
Comparison of cytomorphology and histomorphology in myelodysplastic syndromesKathrin Nachtkamp, Corinna Strupp, Rosa Faoro, et al.
Pageof 34

Showing results (51-60 of 339) with videos related to

Sort By:
Pageof 34
European Journal of Haematology|October 10, 2013
The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in GermanyNorbert Gattermann, Andrea Kündgen, Lenka Kellermann, et al.
Annals of Hematology|June 26, 2008
Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromesUlrich Germing, Carlo Aul, Charlotte M Niemeyer, et al.
Frontiers in Oncology|January 1, 2024
Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potentialAnna Maria Cacic, Felicitas Isabel Schulz, Ulrich Germing, et al.
Chemotherapy|September 6, 2007
Complete remission of a metastatic pancreatic carcinoma after modified G-FLIP therapyIngo Alldinger, Antonis G Tsamaloukas, Ulrich Germing, et al.
Haematologica|June 15, 2004
Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximabHolger Schulz, Hendrik Pels, Ingo Schmidt-Wolf, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemiaBrigitte Royer-Pokora, Detlef Trost, Nicola Müller, et al.
Cancer Genetics and Cytogenetics|February 24, 2006
Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemiaDetlef Trost, Barbara Hildebrandt, Manfred Beier, et al.
British Journal of Haematology|May 12, 2015
In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over timeMichael Lauseker, Jennifer Schemenau, Corinna Strupp, et al.
Leukemia Research|March 17, 2012
Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromesUlrich Germing, Corinna Strupp, Aristoteles Giagounidis, et al.
Frontiers in Oncology|April 26, 2024
Comparison of cytomorphology and histomorphology in myelodysplastic syndromesKathrin Nachtkamp, Corinna Strupp, Rosa Faoro, et al.
Pageof 34